Average Co-Inventor Count = 6.69
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Takeda Pharmaceutical Company Limited (15 from 1,179 patents)
2. Cornell University (3 from 1,361 patents)
3. Tri-institutional Therapeutics Discovery Institute (3 from 8 patents)
4. Takeda Chemical Industries, Inc. (2 from 1,858 patents)
5. Other (1 from 832,843 patents)
6. The Rockefeller University (1 from 712 patents)
22 patents:
1. 12473331 - Macrocyclic compounds as proteasome inhibitors
2. 12378256 - Heterocyclic compound
3. 11834515 - Macrocyclic compounds as proteasome inhibitors
4. 11732005 - Peptidomimetic proteasome inhibitors
5. 11414422 - Substituted pyrido[4,3-b]indoles and azepino[4,5-b]indoles as inhibitors of cGAS
6. 11279713 - Heterocyclic compound and use thereof
7. 11236099 - Heterocyclic compound
8. 11203613 - Peptidomimetic proteasome inhibitors
9. 10654874 - Heterocyclic compound and use thereof
10. 10214508 - Nitrogen-containing heterocyclic compound
11. 10131653 - Heterocyclic compound
12. 9884875 - Heterocyclic compound and use thereof
13. 9527807 - Sulfonamide derivative and use thereof
14. 9499568 - Heterocyclic compound and use thereof
15. 9371320 - Heterocyclic compound